Disclosure: This article may contain affiliate links. If you buy through these links, we may earn a commission at no extra cost to you. Our recommendations are based on editorial criteria, not commission rates.
Omega-3 fatty acids are among the most researched nutrients in human health — and fish oil is the most common way to supplement them. The evidence for EPA and DHA (the two key omega-3s in fish oil) spans cardiovascular health, triglyceride reduction, inflammation, brain function, and fetal development.
But "omega-3 fish oil" on a label tells you very little about whether a product is effective. The amount of EPA and DHA per capsule, the ratio between them, the oxidation state of the oil, and the form (triglyceride vs ethyl ester) all affect whether the supplement delivers on its category's reputation.
This guide covers what the evidence actually supports, how to identify the right dose for your goal, and what to check on the label before buying.
If you take blood thinners (warfarin, aspirin at high doses), have a bleeding disorder, or are scheduled for surgery, discuss omega-3 dosing with your healthcare provider.
EPA and DHA: what they are and why they differ
Omega-3 fatty acids include alpha-linolenic acid (ALA), found in plant foods like flaxseed, walnuts, and chia seeds; eicosapentaenoic acid (EPA); and docosahexaenoic acid (DHA). EPA and DHA are the biologically active forms most studied for health outcomes.
The body can theoretically convert ALA to EPA and DHA, but this conversion is inefficient — typically less than 10% of ALA becomes EPA, and DHA conversion is even lower. This is why fish oil (which directly provides EPA and DHA) is not equivalent to flaxseed oil.
EPA (eicosapentaenoic acid) is primarily studied for:
- Reducing triglycerides
- Anti-inflammatory effects (competes with arachidonic acid for inflammatory enzyme pathways)
- Cardiovascular event reduction in high-dose prescription form (Vascepa)
- Mood — emerging evidence links higher EPA to reduced depression symptoms
DHA (docosahexaenoic acid) is primarily studied for:
- Brain structure and function (DHA is a major structural component of neuronal membranes)
- Fetal brain and eye development (critical during pregnancy)
- Visual function (DHA is concentrated in the retina)
- Also reduces triglycerides but with a slightly different cardiovascular profile than EPA
What the research shows
Triglyceride reduction
This is the most robustly established effect of omega-3 supplementation. Multiple meta-analyses confirm that EPA and DHA reduce fasting triglycerides in a dose-dependent manner. The FDA has approved prescription omega-3 formulations (Vascepa, Lovaza) specifically for this indication at doses of 2–4 grams of EPA+DHA per day.
A 2012 meta-analysis in the American Journal of Clinical Nutrition covering 68 randomized trials found that omega-3 supplementation reduced triglycerides by approximately 14–16% with significant dose-dependence.
Cardiovascular outcomes
The evidence for cardiovascular event prevention is more nuanced:
The REDUCE-IT trial (2018) found that high-dose prescription icosapentaenoic acid (EPA only, 4 g/day as Vascepa) reduced major cardiovascular events by 25% in people with elevated triglycerides already on statins. This was a landmark finding.
However, earlier trials with lower doses of mixed EPA+DHA showed more modest or inconsistent results. The ASCEND trial and ORIGIN trial, both large randomized trials using lower EPA+DHA doses (~1 g/day), showed no significant cardiovascular event reduction in the populations studied.
The current evidence suggests: high-dose EPA (particularly prescription icosapentaenoic acid) in high-risk individuals with elevated triglycerides has strong evidence. Lower-dose mixed EPA+DHA supplementation has weaker evidence for hard cardiovascular endpoints but is still supported for triglyceride reduction and anti-inflammatory effects.
Inflammation and joint health
EPA competes with arachidonic acid for cyclooxygenase and lipoxygenase enzymes, partially reducing production of pro-inflammatory eicosanoids. Multiple trials have found omega-3 supplementation reduces biomarkers of inflammation (CRP, IL-6, TNF-alpha) in a dose-dependent manner.
Randomized trials in rheumatoid arthritis have consistently shown that EPA+DHA supplementation reduces joint tenderness, morning stiffness, and NSAID requirements over 3–6 months.
Brain health
Epidemiological data consistently links higher fish consumption and DHA status with reduced dementia risk, but supplementation trials in people without deficiency have produced more mixed results. DHA supplementation during pregnancy is well-supported for fetal brain development and infant cognitive outcomes.
Dosage
| Goal | Recommended EPA+DHA | Notes |
|---|---|---|
| General health maintenance | 500–1,000 mg/day | Look for at least 500 mg combined EPA+DHA (not total fish oil) |
| Triglyceride reduction | 2,000–4,000 mg/day | Prescription doses used in trials; consult physician |
| Anti-inflammatory support | 1,000–3,000 mg/day | Higher EPA ratios preferred |
| Cardiovascular risk reduction | 1,000–4,000 mg/day | Depends on individual risk; discuss with provider |
| Pregnancy (DHA support) | 200–600 mg DHA/day | Most prenatal vitamins under-dose DHA |
| Rheumatoid arthritis | 3,000 mg/day EPA+DHA | Used in most RA trials |
The critical label-reading point: A "1,000 mg fish oil capsule" may contain only 300 mg of EPA+DHA. The rest is other fats. Always check the supplement facts panel for the actual EPA and DHA content, not just the fish oil mass.
How to evaluate a fish oil product
1. EPA and DHA content per serving
This is the most important number. For general health maintenance, look for at least 500 mg combined EPA+DHA per serving. For therapeutic goals, calculate how many capsules you need to reach the target dose.
2. EPA-to-DHA ratio
Standard fish oil is roughly 18% EPA and 12% DHA (3:2 ratio). High-EPA products (used in mood and cardiovascular applications) have ratios of 3:1 or higher. High-DHA products exist for brain and pregnancy-specific applications. Choose based on your primary goal.
3. Triglyceride vs ethyl ester form
Fish oil is sold in two main molecular forms:
- Triglyceride (TG) form: The natural form found in fish. Better absorbed, particularly with a fat-containing meal.
- Ethyl ester (EE) form: A processed form used in most standard fish oil capsules. Cheaper to produce. Bioavailability is lower, particularly when taken without fat.
- Re-esterified triglyceride (rTG) form: A premium form with absorption similar to natural TG.
Products labeled "natural fish oil," "triglyceride form," or "rTG" have better absorption profiles than standard ethyl ester products.
4. Freshness and oxidation
Omega-3 fatty acids oxidize (go rancid) when exposed to heat, light, and oxygen. Oxidized fish oil may be less effective and potentially harmful. Signs of oxidized oil: fishy burps, strong rancid smell when a capsule is cut open.
Good markers of freshness:
- TOTOX (total oxidation value) below 26
- Peroxide value below 5 meq/kg
- Third-party freshness testing by IFOS (International Fish Oil Standards) or similar
If your fish oil smells strongly fishy when you open a capsule, it is likely oxidized.
5. Contaminants
Fish accumulate mercury, PCBs, and dioxins. Reputable fish oil manufacturers molecularly distill the oil to remove these contaminants. Look for:
- Third-party heavy metal testing (NSF, USP, or IFOS certification)
- Smaller fish species (anchovies, sardines, mackerel) as the source — these accumulate fewer toxins than large predatory fish
Krill oil vs fish oil
Krill oil is often marketed as superior to fish oil because krill phospholipids may offer better cell membrane integration. The evidence for superior bioavailability is real but modest. Krill oil products typically contain far less EPA+DHA per capsule (often 100–200 mg vs 500+ mg in fish oil) at higher cost. For therapeutic doses, fish oil is generally more practical and more affordable.
Side effects
At typical doses (1–3 g EPA+DHA/day):
- Fishy burps and aftertaste (most common; reduced by enteric-coated products or freezing capsules)
- Mild gastrointestinal upset
- Loose stools at higher doses
At higher doses (3+ g/day):
- Increased bleeding time — relevant if you take anticoagulants or NSAIDs
- Reduced platelet aggregation (generally favorable for cardiovascular health but requires medical supervision if you take blood thinners)
Frequently Asked Questions
Bottom line
EPA and DHA from fish oil have some of the most robust evidence in the supplement category — particularly for triglyceride reduction and anti-inflammatory support. People using omega-3s for cardiovascular health should also consider CoQ10, which addresses the energy-production side of heart health and is especially relevant for anyone taking statins. The dose that matters is the EPA+DHA content, not the total fish oil mass. For general health, 500–1,000 mg combined EPA+DHA per day from a fresh, third-party-tested product is a credible baseline. For specific cardiovascular or triglyceride goals, higher doses should be supervised by a physician. Choose triglyceride-form products from small fatty fish sources, take with meals, and discard any oil that smells rancid.
Related Articles
- CoQ10 for Heart Health: Forms, Dosage, and Statins
- How to Improve Gut Health Naturally: Diet and Habits
- How to Support Healthy Blood Sugar After Meals
Sources
- American Journal of Clinical Nutrition 2012: Omega-3 and triglycerides meta-analysis — https://pubmed.ncbi.nlm.nih.gov/22682991/
- New England Journal of Medicine 2018: REDUCE-IT trial — https://pubmed.ncbi.nlm.nih.gov/30145944/
- NIH Office of Dietary Supplements: Omega-3 Fatty Acids — https://ods.od.nih.gov/factsheets/Omega3FattyAcids-HealthProfessional/
- American Heart Association: Omega-3 advisory — https://www.ahajournals.org/doi/10.1161/CIR.0000000000000574
- EFSA 2012: Scientific opinion on EPA and DHA — https://efsa.onlinelibrary.wiley.com/doi/10.2903/j.efsa.2012.2815

